AMNEAL PHARMACEUTICALS, INC. (AMRX) Total liabilities 2017–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) total liabilities at each fiscal year-end, per SEC filings.
$3.7BFY2025 · since FY2017: $0 → $3.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7B | +3.8% |
| FY2024 | $3.6B | +4.6% |
| FY2023 | $3.5B | -1.4% |
| FY2022 | $3.5B | -2.2% |
| FY2021 | $3.6B | -3.3% |
| FY2020 | $3.7B | +7.8% |
| FY2019 | $3.4B | -10.8% |
| FY2018 | $3.8B | — |
| FY2017 | $0 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice